<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03971578</url>
  </required_header>
  <id_info>
    <org_study_id>ASDCLAD001</org_study_id>
    <nct_id>NCT03971578</nct_id>
  </id_info>
  <brief_title>Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses</brief_title>
  <official_title>Screening Device for Autism Spectrum Disorders Using High Stimulation Rate ABR With Continuous Loop Averaging Deconvolution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intelligent Hearing Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Intelligent Hearing Systems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop an Auditory Brainstem Response (ABR) based&#xD;
      neurological screening method to detect increased risk for Autism Spectrum Disorders (ASD)&#xD;
      and other neurological conditions in newborns.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the proposed study, a screening method for neurological deficits, with an emphasis on its&#xD;
      application to ASD, will be developed and its feasibility demonstrated. The proposed method&#xD;
      will utilize high rate stimulation to acquire Auditory Brainstem Responses in order to&#xD;
      determine peak latency and amplitude differences in children with ASD compared to non-ASD.&#xD;
      Similarly to newborn hearing screening, the output of the screening method will provide an&#xD;
      automated pass or refer outcome that can be used by a physician to determine if the child&#xD;
      needs further evaluation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ABR Peak Latency and Amplitude</measure>
    <time_frame>One Week</time_frame>
    <description>ABR Peak Latency and Amplitude</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Autism Spectrum Disorders Group</arm_group_label>
    <description>Children identified as having Autism Spectrum Disorder Age: 3.5 to 4.5 years old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Control Group</arm_group_label>
    <description>Normal children without Autism Spectrum Disorder or other identified developmental disability Age: 3.5 to 4.5 years old</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention Provided</intervention_name>
    <description>No Intervention Provided</description>
    <arm_group_label>Autism Spectrum Disorders Group</arm_group_label>
    <arm_group_label>Normal Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with autism spectrum disorders and normally developing age- and gender-matched&#xD;
        controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children with autism spectrum disorder diagnosis&#xD;
&#xD;
          -  Normally developing age- and gender-matched controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Permanent or temporary hearing loss at the time of testing.&#xD;
&#xD;
          -  Craniofacial abnormalities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>42 Months</minimum_age>
    <maximum_age>54 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine Delgado, PhD</last_name>
    <phone>305-284-2814</phone>
    <email>cdelgado@umiami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rafael Delgado, PhD</last_name>
    <phone>305-668-6102</phone>
    <email>redelgado@ihsys.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Miami Department of Psychology</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franchesca Izquierdo</last_name>
      <phone>305-284-2814</phone>
      <email>UMChildDevelopment@miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christine Delgado, PhD</last_name>
      <phone>305-284-2814</phone>
      <email>cdelgado@umiami.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Miron O, Beam AL, Kohane IS. Auditory brainstem response in infants and children with autism spectrum disorder: A meta-analysis of wave V. Autism Res. 2018 Feb;11(2):355-363. doi: 10.1002/aur.1886. Epub 2017 Oct 31.</citation>
    <PMID>29087045</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2019</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autism Spectrum Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Summary data will be disseminated</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

